TWF2 and neoplasm: Immunohistochemical analysis of paired ccRCC samples from the SYSU cohort further supported the significant upregulation of TWF2 in tumor tissues, especially among patients with sunitinib resistance (Figure 1H,I; Figure S2J, Supporting Information).